{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:25:59Z","timestamp":1740108359469,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00228-021-03137-6","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T03:17:37Z","timestamp":1620616657000},"page":"1523-1529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between the use of hormonal contraceptives and risk of cholecystectomy in women of reproductive age"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3636-8918","authenticated-orcid":false,"given":"Farzin","family":"Khosrow-Khavar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohit","family":"Sodhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Ganjizadeh-Zavareh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahyar","family":"Etminan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,10]]},"reference":[{"key":"3137_CR1","unstructured":"United Nations; Department of Economic and Social Affairs; Population Division (2015) Trends in contraceptive use worldwide. https:\/\/www.un.org\/development\/desa\/pd\/sites\/www.un.org.development.desa.pd\/files\/undesa_pd_report_2015_trends_contraceptive_use.pdf. Accessed 1 Nov 2020"},{"key":"3137_CR2","unstructured":"United Nations; Department of Economic and Social Affairs (2019) Contraceptive use by method. https:\/\/www.un.org\/development\/desa\/pd\/sites\/www.un.org.development.desa.pd\/files\/files\/documents\/2020\/Jan\/un_2019_contraceptiveusebymethod_databooklet.pdf. Accessed 1 Nov 2020"},{"issue":"33","key":"3137_CR3","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","volume":"31","author":"PG Moorman","year":"2013","unstructured":"Moorman PG, Havrilesky LJ, Gierisch JM, Coeytaux RR, Lowery WJ, Peragallo Urrutia R, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER (2013) Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol 31(33):4188\u20134198. https:\/\/doi.org\/10.1200\/JCO.2013.48.9021","journal-title":"J Clin Oncol"},{"issue":"23","key":"3137_CR4","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","volume":"377","author":"LS Morch","year":"2017","unstructured":"Morch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard O (2017) Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med 377(23):2228\u20132239. https:\/\/doi.org\/10.1056\/NEJMoa1700732","journal-title":"N Engl J Med"},{"key":"3137_CR5","doi-asserted-by":"publisher","unstructured":"Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM (2015) Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev (8): CD011054 https:\/\/doi.org\/10.1002\/14651858.CD011054.pub2","DOI":"10.1002\/14651858.CD011054.pub2"},{"issue":"8","key":"3137_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2105\/ajph.83.8.1113","volume":"83","author":"C Thijs","year":"1993","unstructured":"Thijs C, Knipschild P (1993) Oral contraceptives and the risk of gallbladder disease: a meta-analysis. Am J Public Health 83(8):1113\u20131120. https:\/\/doi.org\/10.2105\/ajph.83.8.1113","journal-title":"Am J Public Health"},{"issue":"14","key":"3137_CR7","doi-asserted-by":"publisher","first-page":"e6556","DOI":"10.1097\/MD.0000000000006556","volume":"96","author":"S Wang","year":"2017","unstructured":"Wang S, Wang Y, Xu J, Chen Y (2017) Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: a systematic review and meta-analysis. Medicine (Baltimore) 96(14):e6556. https:\/\/doi.org\/10.1097\/MD.0000000000006556","journal-title":"Medicine (Baltimore)"},{"issue":"15","key":"3137_CR8","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3748\/wjg.15.1886","volume":"15","author":"H Sun","year":"2009","unstructured":"Sun H, Tang H, Jiang S, Zeng L, Chen EQ, Zhou TY, Wang YJ (2009) Gender and metabolic differences of gallstone diseases. World J Gastroenterol 15(15):1886\u20131891. https:\/\/doi.org\/10.3748\/wjg.15.1886","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3137_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12876-017-0678-6","volume":"17","author":"JC Figueiredo","year":"2017","unstructured":"Figueiredo JC, Haiman C, Porcel J, Buxbaum J, Stram D, Tambe N, Cozen W, Wilkens L, Le Marchand L, Setiawan VW (2017) Sex and ethnic\/racial-specific risk factors for gallbladder disease. BMC Gastroenterol 17(1):153. https:\/\/doi.org\/10.1186\/s12876-017-0678-6","journal-title":"BMC Gastroenterol"},{"key":"3137_CR10","unstructured":"US EMR - IQVIA Ambulatory EMR.\u00a0https:\/\/www.iqvia.com\/library\/fact-sheets\/us-only-iqvia-ambulatory-emr. Accessed 1 Sept\u00a02020"},{"issue":"4","key":"3137_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","volume":"2","author":"JL Lund","year":"2015","unstructured":"Lund JL, Richardson DB, Sturmer T (2015) The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application. Curr Epidemiol Rep 2(4):221\u2013228. https:\/\/doi.org\/10.1007\/s40471-015-0053-5","journal-title":"Curr Epidemiol Rep"},{"issue":"3","key":"3137_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.contraception.2012.01.006","volume":"86","author":"S Jick","year":"2012","unstructured":"Jick S, Pennap D (2012) Drospirenone- and levonorgestrel-containing oral contraceptives and the risk of gallbladder disease. Contraception 86(3):220\u2013223. https:\/\/doi.org\/10.1016\/j.contraception.2012.01.006","journal-title":"Contraception"},{"issue":"8","key":"3137_CR13","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1503\/cmaj.110161","volume":"183","author":"M Etminan","year":"2011","unstructured":"Etminan M, Delaney JA, Bressler B, Brophy JM (2011) Oral contraceptives and the risk of gallbladder disease: a comparative safety study. CMAJ 183(8):899\u2013904. https:\/\/doi.org\/10.1503\/cmaj.110161","journal-title":"CMAJ"},{"issue":"2","key":"3137_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/00000658-199902000-00007","volume":"229","author":"S Tierney","year":"1999","unstructured":"Tierney S, Nakeeb A, Wong O, Lipsett PA, Sostre S, Pitt HA, Lillemoe KD (1999) Progesterone alters biliary flow dynamics. Ann Surg 229(2):205\u2013209. https:\/\/doi.org\/10.1097\/00000658-199902000-00007","journal-title":"Ann Surg"},{"issue":"5","key":"3137_CR15","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/0002-9378(84)90735-x","volume":"148","author":"EA Shaffer","year":"1984","unstructured":"Shaffer EA, Taylor PJ, Logan K, Gadomski S, Corenblum B (1984) The effect of a progestin on gallbladder function in young women. Am J Obstet Gynecol 148(5):504\u2013507. https:\/\/doi.org\/10.1016\/0002-9378(84)90735-x","journal-title":"Am J Obstet Gynecol"},{"key":"3137_CR16","unstructured":"US Food and Drug Administration Agency (2016)\u00a0DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/020246s058lbl.pdf. Accessed 15 Nov 2020"},{"issue":"1","key":"3137_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12944-017-0612-5","volume":"16","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Tian W (2017) The effects of progesterones on blood lipids in hormone replacement therapy. Lipids Health Dis 16(1):219. https:\/\/doi.org\/10.1186\/s12944-017-0612-5","journal-title":"Lipids Health Dis"},{"issue":"4","key":"3137_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0010-7824(91)90033-c","volume":"44","author":"K Fahmy","year":"1991","unstructured":"Fahmy K, Khairy M, Allam G, Gobran F, Alloush M (1991) Effect of depo-medroxyprogesterone acetate on coagulation factors and serum lipids in Egyptian women. Contraception 44(4):431\u2013444. https:\/\/doi.org\/10.1016\/0010-7824(91)90033-c","journal-title":"Contraception"},{"key":"3137_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.amsu.2019.04.003","volume":"42","author":"S Hayat","year":"2019","unstructured":"Hayat S, Hassan Z, Changazi SH, Zahra A, Noman M, Zain Ul Abdin M, Javed H, Ans AH (2019) Comparative analysis of serum lipid profiles in patients with and without gallstones: a prospective cross-sectional study. Ann Med Surg (Lond) 42:11\u201313. https:\/\/doi.org\/10.1016\/j.amsu.2019.04.003","journal-title":"Ann Med Surg (Lond)"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03137-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03137-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03137-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T08:09:10Z","timestamp":1631606950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03137-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["3137"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03137-6","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2021,5,10]]},"assertion":[{"value":"29 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study. The University of British Columbia Research Ethics Committee has confirmed that no ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}